Glycomimetics Inc (GLYC)
0.2572 x 2 0.2720 x 60
Pre-market by (Cboe BZX)
0.2610 +0.0103 (+4.11%) 04/25/25 [NASDAQ]
0.2572 x 2 0.2720 x 60
Pre-market 0.2601 -0.0009 (-0.34%) 04:08 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,879 | -36,899 | -46,689 | -63,427 | -51,027 |
| Depreciation Amortization | 35 | 153 | 207 | 265 | 271 |
| Accounts payable and accrued liabilities | -539 | -102 | -1,137 | 18 | 654 |
| Other Working Capital | 1,159 | -2,559 | -4,662 | -1,165 | 3,932 |
| Other Operating Activity | 6,126 | 4,527 | 5,824 | 6,821 | 6,928 |
| Operating Cash Flow | $-31,098 | $-34,880 | $-46,458 | $-57,490 | $-39,242 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 20 | -21 | -84 | -15 | -69 |
| Investing Cash Flow | $20 | $-21 | $-84 | $-15 | $-69 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | 28,824 | 4,157 | 10,724 | 18,144 |
| Financing Cash Flow | $5 | $28,824 | $4,157 | $10,724 | $18,144 |
| Beginning Cash Position | 41,793 | 47,871 | 90,255 | 137,035 | 158,201 |
| End Cash Position | 10,720 | 41,793 | 47,871 | 90,255 | 137,035 |
| Net Cash Flow | $-31,073 | $-6,078 | $-42,384 | $-46,780 | $-21,166 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,098 | -34,880 | -46,458 | -57,490 | -39,242 |
| Capital Expenditure | -10 | -21 | -84 | -15 | -69 |
| Free Cash Flow | -31,108 | -34,901 | -46,542 | -57,504 | -39,310 |